Published Research April 27, 2023 Actions for employers to mitigate cancer risk Advancements in cancer care over the past 20 years have been transformational, driven by updated recommendations in cancer screening, emergence of molecular diagnostic tools to guide treatments, and the development of cutting-edge therapeutics. Each offers the potential for better outcomes, but employers are faced with the challenge of ensuring these often costly tools and treatments are used effectively. In the newly published whitepaper, "Managing Cancer Care in Your Health Plan," Private Health Management (PHM) and Springbuk experts provide insights for employers to improve cancer outcomes and optimize cancer spend. Download the whitepaper now. Read More
News April 26, 2023 Employers can play a significant role in closing the clinical quality gap in cancer In the 2023 "Managing Cancer Care in Your Health Plan" whitepaper, PHM brings clinical insights to Springbuk's claims data from more than 1,000 select employers consisting of 1.7 million lives covered. The paper identifies three areas of opportunities for companies to: Encourage prevention through advanced screenings to achieve better health outcomes at lower treatment costs. Enable molecular profiling, still highly underutilized, to ensure cancers are appropriately characterized and individuals are benefiting from the latest in precision medicine. Optimize drug spend by making informed formulary decisions, not merely restricting use of high-cost drugs. Read More
